Iron beware: A common HFE gene polymorphism may prevent the accurate molecular diagnosis of homozygous hemochromatosis in low-risk, but not high- risk groups

Hepatology

Volumn 31, Issue 2, 2000, Pages 540-542

  Press, Richard D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR;

DIAGNOSTIC ACCURACY; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; NOTE; PHLEBOTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0033950575     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310243     Document Type: Note

References (17)

1. Press RD. Hereditary hemochromatosis: impact of molecular and iron-based testing on the diagnosis, treatment, and prevention of a common, chronic disease. Arch Pathol Lab Med 1999;123:1053-1059.
2. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of Multiple-Cause Mortality Data. Ann Intern Med 1998;129:946-953.
3. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1256-1262.
4. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368-372.
5. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-1119.
6. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Domingo R, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
7. Lebron JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, Bjorkman PJ. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998;93: 111-123.
8. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Sigal E, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 1998;95:1472-1477.
9. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-724.
10. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, Fei Y, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A 1998;95:2492-2497.
11. Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998;114:1003-1008.
12. Jeffrey GP, Chakrabarti S, Hegele RA, Adams PC. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nat Genet 1999;22:325-326.
13. deVilliers JNP, Kotze M. Significance of linkage disequilibrium between mutation C282Y and an Msel polymorphism in population screening and DNA diagnosis of hemochromatosis. Blood Cells Mol Dis 1999;25: 250-252.
14. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ, Jouanolle AM, Mosser A, David V, et al. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Nat Genet 1999;23: 271.
15. Noll WW, Belloni DR, Stenzel TT, Grody WW. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Nat Genet 1999;23:271-272.
16. Gomez PS, Parks S, Ries R, Tran TC, Gomez PF, Press RD. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Nat Genet 1999;23:272.
17. Somerville MJ, Sprysak KA, Hicks M, Elyas BG, Vicen-Wyhony L. An HFE intronic variant promotes misdiagnosis of hereditary hemochromatosis. Am J Hum Genet 1999;65:924-926.